Cardiovascular and Metabolic Disease Research at Novartis 2024: Pioneering Innovations for Global Health
Introduction Cardiovascular and metabolic diseases are among the leading causes of death worldwide, accounting for nearly 18 million fatalities annually. These conditions not only pose significant health risks but also impose a substantial burden on healthcare systems and society. Novartis, a global leader in pharmaceutical research, is dedicated to combating these diseases through innovative research…